Responding to the Needs of an Aging Population
The US HIV epidemic has drastically shifted from primarily a brief, fatal disease of the young to a chronic, manageable illness that people acquire at any age and also grow older with. While the aging of HIV is a welcome consequence of dramatic improvements in HIV care over the past 40 years, it has created […]
Warmer Winters Are Fueling a Surge in Tick-Borne Illnesses
Tick-borne illnesses like Lyme disease are on the rise across the Northeast, fueled by shifting seasonal patterns and warming temperatures. As winters become shorter and milder, blacklegged ticks (commonly known as deer ticks) are staying active well beyond traditional risk windows, posing an extended public health threat to people in affected areas. Andrew Lover, MPH, […]
The Leapfrog Group Releases its Spring 2025 Hospital Safety Grades
Today, the Leapfrog Group released its Spring 2025 Hospital Safety Grades assigning letter grades to each state. States with the highest percentage of A grades for this cycle are Utah, Rhode Island, New Jersey, Connecticut, South Carolina and Virginia.1 Utah ranked number 1 for the fourth consecutive safety grade round, and ties for first among […]
New Microarray Platform Aims to Improve Tick-Borne Disease Diagnosis
A newly developed multiplex protein microarray platform promises to improve the diagnosis of tick-borne diseases by allowing the detection of multiple pathogens in a single test. Published in Scientific Reports in January 2025, the study highlights the effectiveness of this tool in enhancing both sensitivity and specificity for diagnosing tick-borne and other infectious diseases. Multiplex […]
Early Release – Estimation of Incubation Period for Oropouche Virus Disease among Travel-Associated Cases, 2024–2025 – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.A.J. Guagliardo, S. Martin, C.V. Gould, R. Sutter, D. Jacobs, J.E. Staples); Centers […]
Nonrecommended Antivirals Among Medicare Beneficiaries With HIV
This cross-sectional study examines contemporary evidence on the extent to which Medicare beneficiaries with HIV fill older, more toxic antivirals as part of their antiretroviral therapy. Source link
